Utilizing primary patient-derived GBM cells and patient specimens, we showed that FoxM1 activates the stem cell pathways via transcriptional upregulation of Sox2, and this FoxM1-Sox2 signaling axis regulates radioresistance of GBM cells. This evidence concerns the gene FOXM1 and glioblastoma.